stonks4u
Sign up free
PBE logo

PBE Invesco Biotechnology & Genome ETF

New York Stock Exchange Arca · Asset Management · Financial Services

$93.59
-0.63 (-0.67%)

The Invesco Biotechnology & Genome ETF (PBE) seeks to replicate the performance of the Dynamic Biotech & Genome Intellidex Index. This fund typically allocates a minimum of 90% of its total assets to the securities comprising the underlying index. The Index is constructed to achieve capital appreciation by thoroughly evaluating companies based on several investment criteria, including their price …

Market Cap: $285.35Mwww.invesco.com/us/en/financial-products/etfs/invesco-biotechnology-genome-etf.html

Price (90d)

No price history yet — the daily price refresh runs once a day.

Signal Score (90d)

120
100107113120
Aug 12Aug 13

Quote

Day Range
$92.75 – $93.89
52-Week Range
$67.05 – $95.01
Volume
$3.5K
Market Cap
$285.35M
50-Day Avg
$89.06
200-Day Avg
$82.61
Prev Close
$94.22
Open
$93.13

Valuation & Ratios

P/E Ratio
—
EPS
—
P/B Ratio
—
P/S Ratio
—
Debt/Equity
—
Current Ratio
—
Dividend Yield
—
Gross Margin
—

Returns & Efficiency

Return on Equity
—
Return on Assets
—
FCF Yield
—
EV/EBITDA
—

Social Signal Score

61
5d
61
2 mentions
—
30d
61
2 mentions
—
60d
61
2 mentions
—
90d
61
2 mentions
—
news: 2

Valuation

PBEhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.

Mentions (2)

  • Newszacks.com·2d ago·Positive

    Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now? Designed to provide broad exposure to the Health Care ETFs category of the market, the Invesco Biotechnology & Genome ETF (PBE) is a smart beta exchange traded fund launched on 06/23/2005.

    View source ↗
  • Newszacks.com·3d ago·Neutral

    Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)? Launched on June 23, 2005, the Invesco Biotechnology & Genome ETF (PBE) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the equity market.

    View source ↗